Japan· JP-1231014F1054
ジスチグミン臭化物
A distigmine product containing ジスチグミン臭化物, registered in Japan by 鳥居薬品, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Distigmine is registered in 7 of 19 countries.
Countries holding a registration under ATC N07AA03 (distigmine), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 3 of them publish a price we can compare per daily dose
Distigmine · ATC N07AA03
7 / 19 countries
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Polandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ジスチグミン臭化物
- Manufacturer
- 鳥居薬品
- Country
- Japan (JP)
- ATC code
- N07AA03
- ATC class
- Distigmine
- Defined daily dose
- 5 mg, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under N07AA03
Distigmine, as other registers publish it.
- United KingdomDistigmine bromide 5mg tabletsSpecial Order
- United KingdomDistigmine bromide 5mg/5ml oral solutionSpecial Order
- United KingdomDistigmine bromide 5mg/5ml oral suspensionSpecial Order
- PolandUbretidDelfarma Sp. z o.o.
- PolandUbretidCHEPLAPHARM Arzneimittel GmbH
- FinlandUbretidNycomed Austria GmbH
- PolandUbretidInPharm Sp. z o.o.
- GermanyUbretidCheplapharm Arzneimittel Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd906cbf-fa5a-4129-aa49-743b7767c5f5 GET /v1/drugs/bd906cbf-fa5a-4129-aa49-743b7767c5f5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "５ｍｇ１錠",
"marks": "局",
"source": "mhlw",
"remarks": null,
"yj_code": "1231014F1054",
"category": "内用薬",
"price_yen": 11.3,
"generic_name": "ジスチグミン臭化物",
"product_name_jp": null,
"therapeutic_class": "1231",
"transitional_expiry": null
}See everything about distigmine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.